Proposed Substances To Be Evaluated for Toxicological Profile Development, 17177-17178 [2018-08090]

Download as PDF Federal Register / Vol. 83, No. 75 / Wednesday, April 18, 2018 / Notices provide comment should contact the DFO directly. Oral Statements: In general, individuals or groups requesting an oral presentation at a public meeting will be limited to five minutes. Persons interested in providing oral statements at the May 31–June 1, 2018, meeting should contact Mr. Thomas Carpenter, DFO, in writing (preferably via email) at the contact information noted above by May 22, 2018 to be placed on the list of registered speakers. Written Statements: Written statements for the May 31–June 1, 2018, meeting should be received in the SAB Staff Office by March 22, 2018, so that the information can be made available to the SAB for its consideration prior to the meeting. Written statements should be supplied to the DFO at the contact information above via email (preferred) or in hard copy with original signature. Submitters are requested to provide a signed and unsigned version of each document because the SAB Staff Office does not publish documents with signatures on its websites. Members of the public should be aware that their personal contact information, if included in any written comments, may be posted to the SAB website. Copyrighted material will not be posted without explicit permission of the copyright holder. Accessibility: For information on access or services for individuals with disabilities, please contact Mr. Carpenter at the phone number or email address noted above, preferably at least ten days prior to the meeting, to give the EPA as much time as possible to process your request. 17177 Dated: April 12, 2018. Khanna Johnston, Deputy Director, EPA Science Advisory Board Staff Office. [FR Doc. 2018–08135 Filed 4–17–18; 8:45 am] BILLING CODE 6560–50–P FEDERAL COMMUNICATIONS COMMISSION Deletion of Item From Sunshine Act Meeting April 13, 2016. The following item has been deleted from the list of items scheduled for consideration at the Tuesday, April 17, 2018, Open Meeting and previously listed in the Commission’s Notice of April 10, 2018. Item No. Bureau Subject 7 ................... MEDIA ....................................................... TITLE: Amendment of Section 73.624(g) of the Commission’s Rules Regarding Submission of FCC Form 2100, Schedule G, Used to Report TV Stations’ Ancillary or Supplementary Services (MB Docket No. 17–264); Modernization of Media Regulation Initiative (MB Docket No. 17–105). SUMMARY: The Commission will consider a Report and Order that would revise Section 73.624(g) of its rules to reduce broadcaster reporting obligations relating to the provision of ancillary or supplementary services. Federal Communications Commission. Katura Jackson, Federal Register Liaison Officer, Office of the Secretary. [FR Doc. 2018–08207 Filed 4–16–18; 11:15 am] BILLING CODE 6712–01–P Contact Person for More Information: Kimberly Weaver, Director, Office of External Affairs, (202) 942–1640. Dated: April 12, 2018. Dharmesh Vashee, Deputy General Counsel, Federal Retirement Thrift Investment Board. [FR Doc. 2018–08089 Filed 4–17–18; 8:45 am] BILLING CODE P Meeting Agenda; April 23, 2018, In Person, 8:30 a.m. DEPARTMENT OF HEALTH AND HUMAN SERVICES Open Session amozie on DSK30RV082PROD with NOTICES FEDERAL RETIREMENT THRIFT INVESTMENT BOARD Agency for Toxic Substances and Disease Registry 1. Approval of the Meeting Minutes for the March 26, 2018 Board Member Meeting 2. Monthly Reports (a) Participant Activity Report (b) Legislative Report 3. Quarterly Reports (c) Investment Performance (d) Budget Review (e) Audit Status 4. OCFO Annual Report 5. Internal Audit 6. Annual Financial Audit—CLA 7. DOL Presentation 8. IT Update Closed Session Information covered under 5 U.S.C. 552b (c)(9)(B). VerDate Sep<11>2014 17:31 Apr 17, 2018 Jkt 244001 [Docket No. ATSDR–2018–0003] Proposed Substances To Be Evaluated for Toxicological Profile Development Agency for Toxic Substances and Disease Registry (ATSDR), Department of Health and Human Services (HHS). ACTION: Request for comments on proposed substances to be evaluated for Toxicological Profile development. AGENCY: The Agency for Toxic Substances and Disease Registry (ATSDR) within the Department of Health and Human Services is initiating the development of another set of Toxicological Profiles. This notice SUMMARY: PO 00000 Frm 00040 Fmt 4703 Sfmt 4703 solicits public nominations of substances for ATSDR to evaluate for Toxicological Profile development. ATSDR will consider nominations from the Substance Priority List, as well as any non-Comprehensive Environmental Response, Compensation, and Liability Act of 1980 (CERLA) substances that may have public health implications, on the basis of ATSDR’s authority to prepare Toxicological Profiles for substances not found at sites on the National Priorities List. The agency will do so in order to ‘‘. . . establish and maintain inventory of literature, research, and studies on the health effects of toxic substances’’, to respond to requests for consultation, and to support the site-specific response actions conducted by ATSDR, as otherwise necessary. DATES: Nominations from the Substance Priority List and/or additional substances must be submitted by May 18, 2018. ADDRESSES: You may submit nominations, identified by Docket No. ATSDR–2018–0003 by any of the following methods: • Internet: Access the Federal eRulemaking portal at www.regulations.gov. Follow the instructions for submitting comments. • Mail: Division of Toxicology and Human Health Sciences, Agency for E:\FR\FM\18APN1.SGM 18APN1 17178 Federal Register / Vol. 83, No. 75 / Wednesday, April 18, 2018 / Notices Toxic Substances and Disease Registry, 1600 Clifton Rd. NE, MS F–57, Atlanta, GA 30329. Attn: Docket No. ATSDR– 2018–0003. Instructions: All submissions must include the agency name and docket number for this notice. All relevant comments will be posted without change. This means that no confidential business information or other confidential information should be submitted in response to this notice. Refer to the section Submission of Nominations (below) for the specific information required. FOR FURTHER INFORMATION CONTACT: For further information, please contact Susan Z. Ingber, Division of Toxicology and Human Health Sciences, Agency for Toxic Substances and Disease Registry, 1600 Clifton Rd. NE, MS F–57, Atlanta, GA 30329, Email: wng7@cdc.gov; phone: 770.488.0605. SUPPLEMENTARY INFORMATION: The Superfund Amendments and Reauthorization Act of 1986 (SARA) [42 U.S.C. 9601 et seq.] amended the Comprehensive Environmental Response, Compensation, and Liability Act of 1980 (CERCLA or Superfund) [42 U.S.C. 9601 et seq.] by establishing certain requirements for ATSDR and the U.S. Environmental Protection Agency (EPA) with regard to hazardous substances most commonly found at facilities on the CERCLA National Priorities List (NPL). Among these statutory requirements is a mandate for the Administrator of ATSDR to prepare Toxicological Profiles for each substance included on the Priority List of Hazardous Substances. This list identifies 275 hazardous substances that ATSDR and EPA have determined pose the most significant current potential threat to human health. Substances To Be Evaluated for Toxicological Profile Development amozie on DSK30RV082PROD with NOTICES Each year, ATSDR develops a list of substances to be considered for Toxicological Profile development. The nomination process includes consideration of all substances on ATSDR’s Substance Priority List (SPL), as well as other substances nominated by the public. The SPL may be found at the following website: www.atsdr.cdc.gov/SPL. Submission of Nominations for Toxicological Profile Development Today’s notice invites voluntary public nominations for substances included on the SPL and for substances not listed on the SPL. All nominations should include the full name of the nominator, affiliation, and email VerDate Sep<11>2014 17:31 Apr 17, 2018 Jkt 244001 address. When nominating a non-SPL substance, please include the rationale for the nomination. Please note that email addresses will not be posted on regulations.gov. ATSDR will evaluate data and information associated with nominated substances and will determine the final list of substances to be chosen for Toxicological Profile development. Substances will be chosen according to ATSDR’s specific guidelines for selection. These guidelines can be found in the Selection Criteria, which may be accessed at www.atsdr.cdc.gov/ toxprofiles/guidance/ATSDR_TP_ Selection%20Criteria.pdf. Please ensure that your comments are submitted within the specified nomination period. Nominations received after the closing date will be marked as late and may be considered only if time and resources permit. Pamela Protzel Berman, Director, Office of Policy, Planning and Partnerships, Agency for Toxic Substances and Disease Registry. [FR Doc. 2018–08090 Filed 4–17–18; 8:45 am] BILLING CODE 4163–70–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Announcement of Meeting of the Secretary’s Advisory Committee on National Health Promotion and Disease Prevention Objectives for 2030 Office of Disease Prevention and Health Promotion, Office of the Assistant Secretary for Health, Office of the Secretary, Department of Health and Human Services. ACTION: Notice. AGENCY: The U.S. Department of Health and Human Services (HHS) announces the next meeting of the Secretary’s Advisory Committee on National Health Promotion and Disease Prevention Objectives for 2030 (Committee) regarding the development of national health promotion and disease prevention objectives for 2030. This meeting will be held online via webinar and is open to the public. The Committee will discuss the nation’s health promotion and disease prevention objectives and will provide recommendations to improve health status and reduce health risks for the nation by the year 2030. The Committee will further develop recommendations regarding Leading Health Indicators and recommendations for setting targets for the Healthy People 2030 objectives. Pursuant to the Committee’s charter, the Committee’s advice must assist the SUMMARY: PO 00000 Frm 00041 Fmt 4703 Sfmt 4703 Secretary in reducing the number of objectives while ensuring that the selection criteria identifies the most critical public health issues that are high-impact priorities supported by current national data. DATES: The Committee will meet on May 14, 2018, from 1:00 p.m. to 4:00 p.m. Eastern Time (ET). ADDRESSES: The meeting will be held online via webinar. To register to attend the meeting, please visit the Healthy People website at http:// www.healthypeople.gov. FOR FURTHER INFORMATION CONTACT: Emmeline Ochiai, Designated Federal Official, Secretary’s Advisory Committee on National Health Promotion and Disease Prevention Objectives for 2030, U.S. Department of Health and Human Services, Office of the Assistant Secretary for Health, Office of Disease Prevention and Health Promotion, 1101 Wootton Parkway, Room LL–100, Rockville, MD 20852, (240) 453–8280 (telephone), (240) 453– 8281 (fax). Additional information is available on the Healthy People website at http://www.healthypeople.gov. SUPPLEMENTARY INFORMATION: The names and biographies of the Committee members are available at https://www.healthypeople.gov/2020/ about/history-development/healthypeople-2030-advisory-committee. Purpose of Meeting: Through the Healthy People initiative, HHS leverages scientific insights and lessons from the past decade, along with new knowledge of current data, trends, and innovations, to develop the next iteration of national health promotion and disease prevention objectives. Healthy People provides science-based, 10-year national objectives for promoting health and preventing disease. Since 1979, Healthy People has set and monitored national health objectives that meet a broad range of health needs, encourage collaboration across sectors, guide individuals toward making informed health decisions, and measure the impact of our prevention and health promotion activities. Healthy People 2030 health objectives will reflect assessments of major risks to health and wellness, changing public health priorities, and emerging technologies related to our nation’s health preparedness and prevention. Public Participation at Meeting: Members of the public are invited to join the online Committee meeting. There will be no opportunity for oral public comments during this online Committee meeting. However, written comments are welcome throughout the entire development process of the E:\FR\FM\18APN1.SGM 18APN1

Agencies

[Federal Register Volume 83, Number 75 (Wednesday, April 18, 2018)]
[Notices]
[Pages 17177-17178]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-08090]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Agency for Toxic Substances and Disease Registry

[Docket No. ATSDR-2018-0003]


Proposed Substances To Be Evaluated for Toxicological Profile 
Development

AGENCY: Agency for Toxic Substances and Disease Registry (ATSDR), 
Department of Health and Human Services (HHS).

ACTION: Request for comments on proposed substances to be evaluated for 
Toxicological Profile development.

-----------------------------------------------------------------------

SUMMARY: The Agency for Toxic Substances and Disease Registry (ATSDR) 
within the Department of Health and Human Services is initiating the 
development of another set of Toxicological Profiles. This notice 
solicits public nominations of substances for ATSDR to evaluate for 
Toxicological Profile development. ATSDR will consider nominations from 
the Substance Priority List, as well as any non-Comprehensive 
Environmental Response, Compensation, and Liability Act of 1980 (CERLA) 
substances that may have public health implications, on the basis of 
ATSDR's authority to prepare Toxicological Profiles for substances not 
found at sites on the National Priorities List. The agency will do so 
in order to ``. . . establish and maintain inventory of literature, 
research, and studies on the health effects of toxic substances'', to 
respond to requests for consultation, and to support the site-specific 
response actions conducted by ATSDR, as otherwise necessary.

DATES: Nominations from the Substance Priority List and/or additional 
substances must be submitted by May 18, 2018.

ADDRESSES: You may submit nominations, identified by Docket No. ATSDR-
2018-0003 by any of the following methods:
     Internet: Access the Federal eRulemaking portal at 
www.regulations.gov. Follow the instructions for submitting comments.
     Mail: Division of Toxicology and Human Health Sciences, 
Agency for

[[Page 17178]]

Toxic Substances and Disease Registry, 1600 Clifton Rd. NE, MS F-57, 
Atlanta, GA 30329. Attn: Docket No. ATSDR-2018-0003.
    Instructions: All submissions must include the agency name and 
docket number for this notice. All relevant comments will be posted 
without change. This means that no confidential business information or 
other confidential information should be submitted in response to this 
notice. Refer to the section Submission of Nominations (below) for the 
specific information required.

FOR FURTHER INFORMATION CONTACT: For further information, please 
contact Susan Z. Ingber, Division of Toxicology and Human Health 
Sciences, Agency for Toxic Substances and Disease Registry, 1600 
Clifton Rd. NE, MS F-57, Atlanta, GA 30329, Email: [email protected]; phone: 
770.488.0605.

SUPPLEMENTARY INFORMATION: The Superfund Amendments and Reauthorization 
Act of 1986 (SARA) [42 U.S.C. 9601 et seq.] amended the Comprehensive 
Environmental Response, Compensation, and Liability Act of 1980 (CERCLA 
or Superfund) [42 U.S.C. 9601 et seq.] by establishing certain 
requirements for ATSDR and the U.S. Environmental Protection Agency 
(EPA) with regard to hazardous substances most commonly found at 
facilities on the CERCLA National Priorities List (NPL). Among these 
statutory requirements is a mandate for the Administrator of ATSDR to 
prepare Toxicological Profiles for each substance included on the 
Priority List of Hazardous Substances. This list identifies 275 
hazardous substances that ATSDR and EPA have determined pose the most 
significant current potential threat to human health.

Substances To Be Evaluated for Toxicological Profile Development

    Each year, ATSDR develops a list of substances to be considered for 
Toxicological Profile development. The nomination process includes 
consideration of all substances on ATSDR's Substance Priority List 
(SPL), as well as other substances nominated by the public. The SPL may 
be found at the following website: www.atsdr.cdc.gov/SPL.

Submission of Nominations for Toxicological Profile Development

    Today's notice invites voluntary public nominations for substances 
included on the SPL and for substances not listed on the SPL. All 
nominations should include the full name of the nominator, affiliation, 
and email address. When nominating a non-SPL substance, please include 
the rationale for the nomination. Please note that email addresses will 
not be posted on regulations.gov.
    ATSDR will evaluate data and information associated with nominated 
substances and will determine the final list of substances to be chosen 
for Toxicological Profile development. Substances will be chosen 
according to ATSDR's specific guidelines for selection. These 
guidelines can be found in the Selection Criteria, which may be 
accessed at www.atsdr.cdc.gov/toxprofiles/guidance/ATSDR_TP_Selection%20Criteria.pdf.
    Please ensure that your comments are submitted within the specified 
nomination period. Nominations received after the closing date will be 
marked as late and may be considered only if time and resources permit.

Pamela Protzel Berman,
Director, Office of Policy, Planning and Partnerships, Agency for Toxic 
Substances and Disease Registry.
[FR Doc. 2018-08090 Filed 4-17-18; 8:45 am]
BILLING CODE 4163-70-P